Cargando…

Side effects of drugs annual. a worldwide yearly survey of new data in adverse drug reactions / Volume 37 :

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a rel...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ray, Sidhartha D. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam, Netherlands : Elsevier, 2015.
Temas:
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000cam a2200000Ii 4500
001 SCIDIR_ocn929886684
003 OCoLC
005 20231120112035.0
006 m o d
007 cr bnu|||aucuu
008 151118s2015 ne o 001 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d N$T  |d IDEBK  |d YDXCP  |d OCLCQ  |d DEBBG  |d D6H  |d AU@  |d OPELS  |d OCLCQ  |d OPELS  |d INARC  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 930336711 
020 |a 9780444635310  |q (electronic bk.) 
020 |a 0444635319  |q (electronic bk.) 
020 |z 9780444635259 
020 |z 0444635254 
035 |a (OCoLC)929886684  |z (OCoLC)930336711 
050 4 |a RM302.5 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.7/042  |2 23 
245 0 0 |a Side effects of drugs annual.  |n Volume 37 :  |b a worldwide yearly survey of new data in adverse drug reactions /  |c edited by Sidhartha D. Ray. 
264 1 |a Amsterdam, Netherlands :  |b Elsevier,  |c 2015. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Includes indexes. 
588 0 |a Online resource; title from PDF title page (ScienceDirect, viewed November 18, 2015). 
505 0 |a Title page; Table of Contents; Copyright; Contributors; Preface; Special Reviews in SEDA 37; Table of Essays, Annuals 1-36; Abbreviations; ADRs, ADEs and SEDs: A Bird's Eye View; I Introduction; References on Adverse Drug Reactions; II Pharmacogenomics Considerations; References Pharmacogenomics Considerations; III Immunological Reactions; References; IV Analysis of Toxicological Reactions; References; V Grades of Adverse Drug Reactions; References; VI FDA Pregnancy Categories/Classification of teratogenicity; References; Conclusion. 
505 8 |a Chapter 1: Central Nervous System Stimulants and Drugs That Suppress AppetiteAbstract; Methylxanthines; Vigilance Promoting Drugs; Parasympathomimetics [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; Chapter 2: Antidepressants; Abstract; General; Selective Serotonin Re-Uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35, 30; SEDA-36, 14]; Serotonin and Noradrenaline Re-Uptake Inhibitors (SNRIs); Other Antidepressants; Chapter 3: Lithium; Abstract; Introduction; Organs and Systems; Second-Generation Effects; Susceptibility Factors; Interactions. 
505 8 |a Diagnosis of Adverse Drug ReactionsManagement of Adverse Drug Reactions; Pharmacogenomics; Chapter 4: Drugs of Abuse; Abstract; Introduction; Cannabinoid; Alcohol; Benzodiazepines; Sympathomimetics-Cocaine; Opioids-Heroin; Electronic Cigarettes (E-Cigarettes); Conclusion; Chapter 5: Hypnosedatives and Anxiolytics; Abstract; Benzodiazepines; Hypnosedatives and Benzodiazepine-Like Drugs; Chapter 6: Antipsychotic Drugs; Abstract; General [SEDA-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51; SEDA-35, 85; SEDA-36, 59]; Individual Drugs; Acknowledgements; Chapter 7: Antiepileptics; Abstract. 
505 8 |a Chapter 8: Opioid Analgesics and Narcotic AntagonistsAbstract; Opioid Receptor Agonists; Alfentanil [SED-15, 72; SEDA-34, 152; SEDA-35, 173; SEDA-36, 108]; Codeine [SED-15, 880; SEDA -34, 152; SEDA-35, 174; SEDA-36, 108]; Dextrometrophan [SED-15, 1088; SEDA-34, 153; SEDA-35, 174; SEDA-36, 108]; Diamorphine [SED-15, 1096; SEDA-34, 153; SEDA-35, 175; SEDA-36, 108]; Dihydrocodeine [SED-15, 1125; SEDA-34, 154; SEDA-35, 175; SEDA-36, 108]; Fentanyl [SED-15, 1346; SEDA-34, 154; SEDA-35, 176; SEDA-36, 109]; Hydrocodone [SED-15, 1702; SEDA-34, 156; SEDA-35, 177; SEDA-36, 109] 
505 8 |a Methadone [SED-15, 2270 SEDA-34, 157; SEDA-35, 177; SEDA-36, 110]; Morphine [SED-15, 2386; SEDA-34, 159; SEDA-35, 181; SEDA-36, 111]; Oxycodone [SED-15, 2651; SEDA-34, 161; SEDA-35, 182; SEDA-36, 111]; Papaverine [SED-15, 2678; SEDA-34, 162; SEDA-35, 183; SEDA-36, 112]; Pethidine (Meperidine) [SED-15, 2791; SEDA-34, 163; SEDA-35, 183; SEDA-36, 112]; Remifentanyl [SED-15, 3030; SEDA-34, 163; SEDA-35, 184; SEDA-36, 112]; Tramadol [SED-15, 3469; SEDA-34, 165; SEDA-35, 184; SEDA-36, 112]; Partial Opioid Receptor Agonists; Opioid Receptor Antagonists; Naloxone [SED-15, 2421. 
520 |a Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing each year. Topics covered in this release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressant drugs, Lithium, Drugs of abuse, Hypnotics and sedatives, Antipsychotic Drugs, and much more. 
650 0 |a Drugs  |x Side effects. 
650 2 |a Drug-Related Side Effects and Adverse Reactions  |0 (DNLM)D064420 
650 6 |a M�edicaments  |x Effets secondaires.  |0 (CaQQLa)201-0002241 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Drugs  |x Side effects  |2 fast  |0 (OCoLC)fst00898912 
700 1 |a Ray, Sidhartha D.,  |e editor. 
776 0 8 |i Print version:  |z 0444635254  |z 9780444635259  |w (OCoLC)919479584 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780444635259  |z Texto completo 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/03786080/37  |z Texto completo